Michael Joseph Sernyak

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi Impact of clozapine on completed suicide
    M J Sernyak
    Psychiatry Service 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Ave, West Haven, CT 06516, USA
    Am J Psychiatry 158:931-7. 2001
  2. ncbi Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006
    Michael J Sernyak
    Department of Psychiatry, Yale University, New Haven, CT 06516, USA
    Psychiatr Serv 59:567-9. 2008
  3. ncbi Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications
    Michael Joseph Sernyak
    Psychiatry Service, 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Avenue, West Haven, CT 06516, USA
    Adm Policy Ment Health 34:540-7. 2007
  4. ncbi Experience of VA psychiatrists with pharmaceutical detailing of antipsychotic medications
    Michael Sernyak
    Psychiatry Service, Department of Veterans Affairs Connecticut Healthcare System, 950 Campbell Ave, West Haven, CT 06516, USA
    Psychiatr Serv 58:1292-6. 2007
  5. ncbi Implementation of monitoring and management guidelines for second-generation antipsychotics
    Michael J Sernyak
    Yale University School of Medicine and Veterans Affairs Connecticut Healthcare System, West Haven, Conn, USA
    J Clin Psychiatry 68:14-8. 2007
  6. ncbi Generic fluoxetine and choice of antidepressant medication
    Michael J Sernyak
    Psychiatry Service, 116A, Veterans Affairs Connecticut Healthcare System, 950 Campbell Ave, West Haven, CT 06516, USA
    Psychiatr Serv 58:128-30. 2007
  7. ncbi Undiagnosed hyperglycemia in patients treated with atypical antipsychotics
    Michael J Sernyak
    Psychiatry Service 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Avenue, West Haven, CT 06516, USA
    J Clin Psychiatry 66:1463-7. 2005
  8. ncbi Clinicians' reasons for antipsychotic coprescribing
    Michael J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT 06516, USA
    J Clin Psychiatry 65:1597-600. 2004
  9. ncbi Predictors of antipsychotic medication change
    Michael J Sernyak
    Psychiatry Service, 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Ave, West Haven, CT 06516, USA
    J Behav Health Serv Res 32:85-94. 2005
  10. ncbi Economic grand rounds: systemwide costs associated with second-generation antipsychotics in the treatment of schizophrenia
    Michael J Sernyak
    Psychiatry Service, Department of Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    Psychiatr Serv 55:1361-2. 2004

Detail Information

Publications20

  1. ncbi Impact of clozapine on completed suicide
    M J Sernyak
    Psychiatry Service 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Ave, West Haven, CT 06516, USA
    Am J Psychiatry 158:931-7. 2001
    ..Clozapine has been found to be superior to typical neuroleptics in ameliorating the symptoms of refractory schizophrenia. This study evaluated clozapine's effect on the rate of death due to suicide...
  2. ncbi Antipsychotic use in the treatment of outpatients with schizophrenia in the VA from fiscal years 1999 to 2006
    Michael J Sernyak
    Department of Psychiatry, Yale University, New Haven, CT 06516, USA
    Psychiatr Serv 59:567-9. 2008
    ..This study examined changes in prescribing patterns of antipsychotic medications to treat schizophrenia...
  3. ncbi Clinicians' reasons for deviations from recommended dosing practices for antipsychotic medications
    Michael Joseph Sernyak
    Psychiatry Service, 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Avenue, West Haven, CT 06516, USA
    Adm Policy Ment Health 34:540-7. 2007
    ..This study was designed to investigate clinician rationales for prescribing higher than recommended dosages of antipsychotic medications in patients with schizophrenia...
  4. ncbi Experience of VA psychiatrists with pharmaceutical detailing of antipsychotic medications
    Michael Sernyak
    Psychiatry Service, Department of Veterans Affairs Connecticut Healthcare System, 950 Campbell Ave, West Haven, CT 06516, USA
    Psychiatr Serv 58:1292-6. 2007
    ..It specifically focused on the experiences of these physicians with representatives of the manufacturers of second-generation antipsychotics...
  5. ncbi Implementation of monitoring and management guidelines for second-generation antipsychotics
    Michael J Sernyak
    Yale University School of Medicine and Veterans Affairs Connecticut Healthcare System, West Haven, Conn, USA
    J Clin Psychiatry 68:14-8. 2007
    ....
  6. ncbi Generic fluoxetine and choice of antidepressant medication
    Michael J Sernyak
    Psychiatry Service, 116A, Veterans Affairs Connecticut Healthcare System, 950 Campbell Ave, West Haven, CT 06516, USA
    Psychiatr Serv 58:128-30. 2007
    ..This study examined whether its availability was associated with an increase in use compared with other medications...
  7. ncbi Undiagnosed hyperglycemia in patients treated with atypical antipsychotics
    Michael J Sernyak
    Psychiatry Service 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Avenue, West Haven, CT 06516, USA
    J Clin Psychiatry 66:1463-7. 2005
    ..This study was designed to determine the proportion of undiagnosed hyperglycemia in patients receiving a broad range of atypical antipsychotics...
  8. ncbi Clinicians' reasons for antipsychotic coprescribing
    Michael J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, West Haven, CT 06516, USA
    J Clin Psychiatry 65:1597-600. 2004
    ..This study was designed to systematically survey clinicians about their rationale for prescribing more than 1 antipsychotic for specific patients...
  9. ncbi Predictors of antipsychotic medication change
    Michael J Sernyak
    Psychiatry Service, 116A, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Ave, West Haven, CT 06516, USA
    J Behav Health Serv Res 32:85-94. 2005
    ..Controlling for independent sociodemographic, diagnostic, and functional measures, frequency of clinical contact was the most robust predictor of switching antipsychotics...
  10. ncbi Economic grand rounds: systemwide costs associated with second-generation antipsychotics in the treatment of schizophrenia
    Michael J Sernyak
    Psychiatry Service, Department of Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    Psychiatr Serv 55:1361-2. 2004
  11. ncbi Neuroleptic use in the treatment of Post-Traumatic Stress Disorder
    M J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, West Haven Campus, 950 Campbell Avenue, West Haven, CT 06516, USA
    Psychiatr Q 72:197-213. 2001
    ....
  12. ncbi Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia
    Michael J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, West Haven, 06516, USA
    Am J Psychiatry 159:561-6. 2002
    ..This study used administrative data from a large national sample of patients with a diagnosis of schizophrenia to compare the prevalence of diabetes mellitus in patients receiving prescriptions for atypical and typical neuroleptics...
  13. ncbi Prescribers' nonadherence to treatment guidelines for schizophrenia when prescribing neuroleptics
    Michael J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    Psychiatr Serv 54:246-8. 2003
    ..The results suggest that patients' agreement with treatment guidelines should be taken into account in the evaluation of prescribers' use of such guidelines...
  14. ncbi Use of system-wide outcomes monitoring data to compare the effectiveness of atypical neuroleptic medications
    Michael J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, West Haven 06516, USA
    Am J Psychiatry 160:310-5. 2003
    ..Outcomes monitoring data in a large health care system were used to evaluate the effectiveness of atypical neuroleptic medications in actual clinical practice...
  15. ncbi Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia
    Michael J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, and Yale University School of Medicine, New Haven, Conn, USA
    J Clin Psychiatry 64:605-8. 2003
    ..This study was designed to investigate the proportion of undiagnosed impaired fasting glucose and diabetes mellitus in patients prescribed clozapine at 8 Department of Veterans Affairs (VA) medical centers...
  16. ncbi Risk adjustment in studies using administrative data
    Michael J Sernyak
    Psychiatry Service, VA Connecticut Healthcare System, Mental Illness Research, Education, and Clinical Center, West Haven 06516, USA
    Schizophr Bull 29:267-71. 2003
    ....
  17. ncbi Rethinking antipsychotic formulary policy
    R A Rosenheck
    Yale Medical School, New Haven, CT, USA
    Schizophr Bull 34:375-80. 2008
    ..The algorithm outlined here and the process for its implementation are intended as a stimulus for discussion of potential policy responses, not as a finalized proposition...
  18. ncbi The effects of federal versus state funding and academic affiliation on mental health services
    Rani A Desai
    Northeast Program Evaluation Center, VA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, CT 06516, USA
    Adm Policy Ment Health 32:267-83. 2005
    ..These findings suggest that, unlike findings from the general medical literature, academic affiliation is unrelated to the quality and delivery of mental health care...
  19. ncbi Results of a naturalistic study of treatment options: switching atypical antipsychotic drugs or augmenting with valproate
    Joyce A Cramer
    Department of Psychiatry, Yale University School of Medicine, New Haven, USA
    Clin Ther 26:905-14. 2004
    ..Combination therapy with atypical antipsychotic agents has not been well studied. Duration of persistence with a prescribed treatment regimen can be used to estimate overall treatment success...
  20. ncbi Utilizing VA information technology to develop psychiatric resident prescription profiles
    Robert Rohrbaugh
    Yale School of Medicine, Department of Psychiatry, 300 George St, Suite 901, Room 24, New Haven, CT 06511, USA
    Acad Psychiatry 33:27-30. 2009
    ..The authors report on a procedure utilizing U.S. Department of Veterans Affairs' computerized pharmacy records to efficiently construct comprehensive individual psychiatric resident prescription practice profiles...